MBTPS1 and diabetic kidney disease: Previous reports showed that neutral ceramidase, SK activity, and S1P levels were all significantly increased in isolated glomeruli from rats treated with streptozotocin (STZ) for 4 days, suggesting a possible involvement of S1P in the glomerular proliferative response in the early-stage of DKD [59].